Currently, there are many hurdles that need to be overcome with real-world data (RWD) before it can be completely integrated into precision medicine oncology. An important issue is how RWD is being collected. One avenue for RWD collection is biospecimens. However, novel technologies such as ‘lab-on-a-chip’ are starting to emerge.
In Oncology Central‘s ‘Ask the Experts’ feature, a panel with expertise including research, clinical practice and policy development will provide perspectives on the applications, challenges and future of the collection of biospecimens, and how RWD can be used to advance the field of precision medicine.
The experts are Lawrence Johnson (ICON, MD, USA), Deborah Collyar (Patient Advocates In Research, CA, USA) and Don Ingber (The Wyss Institute for Biologically Inspired Engineering, MA, USA). Meet the experts here.
Check out the discussion that looks at the major challenges of collecting biospecimens, and the future of RWD and precision medicine.